Brain Cancer Clinical Trials

Showing 441-460 of 693 trials

Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

NCT01635283

The primary purpose of this phase II clinical trial is to determine the safety and effect on survival of patients autologous dendritic cells pulsed with autologous tumor lysate as a treatment for low-grade glioma patients. Other goals of this study are to determine if the vaccine can cause an immune response against patients' cancer cells and slow the growth of their brain tumors

Adult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+2 more

Jonsson Comprehensive Cancer Center5 participantsStarted Jan 2012

Los Angeles, California, United States

TERMINATEDPHASE1/PHASE2

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

NCT02709889

The primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.

Malignant MelanomaMedullary Thyroid CancerGlioblastoma+5 more

AbbVie200 participantsStarted Sep 2016

Gilbert, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +27 more locations

Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Related Searches

Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma

11C-Methionine PET as Prognostic Marker of Gliomas

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome

NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

The Impact of Anesthesia on High- Grade Glioma Patients

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women

Potentiation of Chemotherapy in Brain Tumors by Zinc

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma

HMPL-813 in Treating Patients With Glioblastoma

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Comparing Immobilisation Shells in Cranial Radiotherapy

Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists

68Ga-citrate PET/MR Imaging for Glioma